Emyria Ltd · ASX:EMD

Mr Greg Hutchinson exercised options for 9,500,000 Emyria Ltd shares (Appendix 3Y, ASX)

Traded Nov 16, 2026 · Filed Nov 18, 2026

On Nov 16, 2026, Mr Greg Hutchinson (Director) exercised options for 9,500,000 Emyria Ltd shares. Filed Nov 18, 2026 (Appendix 3Y, ASX).

Options exercised
9,500,000 shares
Role
Director

The filing in full

Appendix 3Y

Change of Director’s Interest Notice

*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*

Introduced 30/09/01 Amended 01/01/11

Name of entityEmyria Limited
ACN625 085 734

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director
for the purposes of section 205G of the Corporations Act.

Name of DirectorMr Greg Hutchinson
Date of last notice29 May 2026

Part 1 - Change of director’s relevant interests in securities

*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed
in this part.

Direct or indirect interestIndirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.Gregory Ross Hutchinson - trustee and beneficiary of the account
Date of change16 November 2026
No. of securities held prior to changeGregory Ross Hutchinson - trustee and beneficiary of the account 42,654,762 fully paid ordinary shares. 2,500,000 performance rights (expiring 28 March 2028). 25,580,000 Performance rights (expiring 28 May 2031). 5,000,000 Options exercisable at $0.051 each on or before 28 March 2028. 3,000,000 unlisted Options exercisable at $0.10 each on or before 7 May 2027. 2,527,777 unlisted options exercisable at $0.05 each on or before on 1 March 2027. 10,663,691 unlisted options exercisable at $0.05 each and expiring on 22 March 2027.
ClassFully paid ordinary shares. Performance rights (expiring 28 May 2031).
Number acquired9,500,000 fully paid ordinary shares
Number disposed9,500,000 performance rights (expiring 28 May 2031)

---

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuationNil – exercise of vested performance rights into fully paid ordinary shares pursuant to the terms and conditions of the Company’s Employee Incentive Plan.
No. of securities held after changeGregory Ross Hutchinson - trustee and beneficiary of the account 52,154,762 fully paid ordinary shares. 2,500,000 performance rights (expiring 28 March 2028). 16,080,000 Performance rights (expiring 28 May 2031). 5,000,000 Options exercisable at $0.051 each on or before 28 March 2028. 3,000,000 unlisted Options exercisable at $0.10 each on or before 7 May 2027. 2,527,777 unlisted options exercisable at $0.05 each on or before on 1 March 2027. 10,663,691 unlisted options exercisable at $0.05 each and expiring on 22 March 2027.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-backExercise of 9,500,000 vested performance rights into 9,500,000 fully paid ordinary shares pursuant to the terms and conditions of the Company’s Employee Incentive Plan.

Part 2 – Change of director’s interests in contracts – N/A

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed
in this part.
Detail of contract N/A

Detail of contractN/A
Nature of interestN/A
Name of registered holder (if issued securities)N/A
Date of changeN/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changedN/A
Interest acquiredN/A
Interest disposedN/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuationN/A
Interest after changeN/A

+ Part 3 – Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?No

---

If so, was prior written clearance provided to allow the trade to proceed during this period?N/A
If prior written clearance was provided, on what date was this provided?N/A

---

Appendix 3Y

Change of Director’s Interest Notice

*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*

Introduced 30/09/01 Amended 01/01/11

Name of entityEmyria Limited
ACN625 085 734

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director
for the purposes of section 205G of the Corporations Act.

Name of DirectorDr Michael Winlo
Date of last notice29 May 2026

Part 1 - Change of director’s relevant interests in securities

*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed
in this part.

Direct or indirect interestDirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.-
Date of change16 November 2026

---

No. of securities held prior to changeMichael Gordon Winlo* • 1,324,230 fully paid ordinary shares. • 200,000 unlisted options exercisable at $0.10 each on or before 7 May 2027. • 2,000,000 unlisted options exercisable $0.051 each on or before 28 March 2028. • 69,444 unlisted options exercisable at $0.05 each on or before 1 March 2027. • 331,058 unlisted options exercisable at $0.05 each on or before 22 March 2027. • 4,500,000 Performance rights (expiring 28 May 2031).ClassMichael Gordon Winlo - trustee and beneficiary of the account 3,000,000 unlisted Options exercisable at $0.296 each on or before 23 November 2026. *32,148 unlisted options exercisable at $0.12 expired on 5 October 2026.Number acquiredFully paid ordinary shares. Performance rights (expiring 28 May 2031).Number disposed1,000,000 fully paid ordinary sharesValue/Consideration Note: If consideration is non-cash, provide details and estimated valuation1,000,000 performance rights (expiring 28 May 2031)No. of securities held after changeNil – exercise of vested performance rights into fully paid ordinary shares pursuant to the terms and conditions of the Company’s Employee Incentive Plan.Michael Gordon Winlo • 2,324,230 fully paid ordinary shares. • 200,000 unlisted options exercisable at $0.10 each on or before 7 May 2027. • 2,000,000 unlisted options exercisable $0.051 each on or before 28 March 2028. • 69,444 unlisted options exercisable at $0.05 each on or before 1 March 2027. • 331,058 unlisted options exercisable at $0.05 each on or before 22 March 2027. • 3,500,000 Performance rights (expiring 28 May 2031).Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-backMichael Gordon Winlo - trustee and beneficiary of the account 3,000,000 unlisted Options exercisable at $0.296 each on or before 23 November 2026.Exercise of 1,000,000 vested performance rights into 1,000,000 fully paid ordinary shares pursuant to the terms and conditions of the Company’s Employee Incentive Plan.

---

Part 2 – Change of director’s interests in contracts – N/A

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed
in this part.

Detail of contractN/A
Nature of interestN/A
Name of registered holder (if issued securities)N/A
Date of changeN/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changedN/A
Interest acquiredN/A
Interest disposedN/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuationN/A
Interest after changeN/A

+ Part 3 – Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?No
If so, was prior written clearance provided to allow the trade to proceed during this period?N/A
If prior written clearance was provided, on what date was this provided?N/A
DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Fully paid ordinary shares. Performance rights (expiring 28 May 2031).Option exercise9,500,000

Source

Download PDF · View original at ASX

Related